Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Science (New York, N.Y.) | Mar 23, 2001

Expanded polyglutamine repeats have been proposed to cause neuronal degeneration in Huntington's disease (HD) and related disorders, through abnormal interactions with other proteins containing short polyglutamine tracts such as the transcriptional coactivator CREB binding protein, CBP. We found that CBP was depleted from its normal nuclear location and was present in polyglutamine aggregates in HD cell culture models, HD transgenic mice, and human HD postmortem brain. Expanded polyglutamine repeats specifically interfere with CBP-activated gene transcription, and overexpression of CBP rescued polyglutamine-induced neuronal toxicity. Thus, polyglutamine-mediated interference with CBP-regulated gene transcription may constitute a genetic gain of function, underlying the pathogenesis of polyglutamine disorders.

Pubmed ID: 11264541 RIS Download

Mesh terms: Animals | Brain | CREB-Binding Protein | Cell Nucleus | Cell Survival | Cells, Cultured | Humans | Huntington Disease | Mice | Mice, Transgenic | Mutation | Nerve Tissue Proteins | Neurons | Nuclear Proteins | Peptides | Repetitive Sequences, Amino Acid | Trans-Activators | Transcription, Genetic | Transfection | Tumor Cells, Cultured

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: NS16375
  • Agency: NINDS NIH HHS, Id: NS34172
  • Agency: NINDS NIH HHS, Id: NS37090
  • Agency: NINDS NIH HHS, Id: NS38144

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.